-
2021 National Primary Health Assembly convenes to announce 6 key tasks
Time of Update: 2021-03-22
It is mentioned in the provincial-level communication materials of this meeting that Guangdong Province guides the medical community to innovate the internal personnel and salary distribution system, establish an incentive mechanism for benefit sharing, share development results, and share profit increments; Superimposed on the policy of “first-class financial supply, second-class performance management” for grassroots medical and health institutions, grassroots medical staff get reasonable remuneration by relying on high-quality services and more work.
-
Hengrui Medicine Carrelizumab and Famitinib clinical trials approved by FDA
Time of Update: 2021-03-22
Up to now, the accumulated research and development expenses of carrelizumab for injection related projects are approximately RMB 1.
After inquiries, famitinib malate currently has sorafenib, sunitinib, pezopanib and other similar products approved for marketing at home and abroad.
-
To Biao Qilu!
Time of Update: 2021-03-22
Source: official website of the State Food and Drug Administration, Mi Nei. com database Medical Network News on March 8 Recently, Jiangsu Haosen Pharmaceutical has reported frequent successes, following the first review of Decitabine for injection.
-
Top 10 most innovative pharmaceutical companies: Pfizer, AZ, GSK...
Time of Update: 2021-03-22
From the biotech companies behind the first mRNA vaccines (Pfizer BioNTech and Moderna) to real estate developers providing high-quality affordable housing (Stablegold Hospitality), the world’s 50 most innovative companies are committed to solving COVID-19 transformation Society.
-
Drug rebates, medical corruption, will become the focus of future investigation and prosecution!
Time of Update: 2021-03-22
33422。 ，，、，20201220。 ，，，。 、：、；；、、。，61。 ，。 219，《》，。290，，，。 ，《 》，。，，，，。 ： ，??。 ，《（2020）》（《》）《（2020）》，。 《》，、、、、，。 ，，，、、，。 ，2021，，。 《》，、，，、、、。 ，、、、。 ，、、、。，，。 ：、 ，。，60%，。 1，《： 》，。，，、，。 ，，。，。、，、、、、，、、，。，，、，，，。 This time the Ministry of Finance issued a document that takes Shandong Province as a typical example, or means that in the future, regular audits of key listed companies and large-scale pharmaceutical companies will be conducted, and industry problems may be discovered, which may cause common problems such as high rebates and high sales expenses.
-
Domestic heavy-weight new drugs have been approved, innovative drug product selection is the key!
Time of Update: 2021-03-22
Taltazep is the first domestically produced Chinese drug for the treatment of systemic lupus erythematosus that has been approved for marketing in China in more than 60 years.
-
20 gynaecological Chinese medicine pharmacies sell out! Enway, a thousand golds, steps...
Time of Update: 2021-03-22
311 ，。，，，202080%。，“”。TOP20，11，、、5“”；、、。TOP20，、、。 20！、、……11“” ，20，2020，。，，80%。 2020E（：） ： ，“”，。2，，、、51。 2020ETOP20 ： ：* TOP20，11，、、、9，，、、5“”；、、。，，11；，8。 2020ETOP20 ： TOP20，、、，、、TOP20。 ， （：） ： 。，1，。，，、、，，、、、13，。，、，、、，。 The market share of the three major products of Zhuzhou Qianjin Pharmaceutical in recent years in physical pharmacies in key cities of gynecological Chinese patent medicines Source: Mi Nei. com's terminal competition pattern of physical pharmacies in key cities Gynecological Qianjin Tablets and Gynecological Qianjin Capsules are exclusive products of Zhuzhou Qianjin Pharmaceutical.
-
National physician license electronic acceleration! Claim rate of more than 90%
Time of Update: 2021-03-22
In September 2019, the Medical Administration and Hospital Administration of the Health Commission issued the "Notice on Further Strengthening the Verification and Management of Electronic Registration Information of Medical Institutions, Physicians, and Nurses".
-
Research on Collaborative Innovation Development of Biomedicine Industry in Guangdong-Hong Kong-Macao Greater Bay Area
Time of Update: 2021-03-22
The Guangdong-Hong Kong-Macao Greater Bay Area is an important area where my country’s biomedical industry gathers. It has a complete industrial foundation and leading strength. With the developmen
-
1 billion injections! Qi Lu and Haisco have just passed the review and Yuandong is here
Time of Update: 2021-03-22
0 Chinese Drug Evaluation DatabaseThere are 15 manufacturers of Palonosetron Hydrochloride Injection including Qilu Pharmaceutical (Hainan), Zhengda Tianqing Pharmaceutical Group, Yangtze River Sichuan Hairong Pharmaceutical, Jiangsu Hengrui Pharmaceutical, among which Qilu Pharmaceutical (Hainan) and Liaoning Haisco The two pharmaceutical companies have been approved for supplementary applications.
-
The number of people insured reaches 1.3 billion, and they seek medical treatment in different places...All the statistics of medical insurance you care about are here
Time of Update: 2021-03-22
84 billion medical expenses for patients with COVID-19 At the beginning of last year, the National Medical Insurance Agency stated that in the treatment of patients with new coronary pneumonia, it is ensured that patients will not be affected by cost issues and that medical institutions will not be affected by payment policies.
-
Key words of the Report on the Work of the Government: promoting innovation, expanding collection, health care reform, and platform anti-monopoly
Time of Update: 2021-03-22
Use market mechanism to encourage enterprise innovation Strengthen the dominant position of enterprise innovation, encourage leading companies to form innovative consortia, expand channels for integration of industry, university, research and use, improve the property rights incentive mechanism for scientific and technological achievements, improve the regulatory system and development policy of venture capital, and promote mass entrepreneurship innovation in depth.
-
Shaanxi Provincial Food and Drug Administration issued 332 standards for traditional Chinese medicine formula granules
Time of Update: 2021-03-22
Source: Shaanxi Provincial Drug AdministrationOn March 9, the Shaanxi Provincial Drug Administration issued an announcement on the "Shaanxi Provincial Standards for Traditional Chinese Medicine Formula Granules" (Volumes 1 and 2), and this standard shall come into force on the date of issuance.
-
Huawei vice president appointed as CEO of Yunnan Baiyao
Time of Update: 2021-03-22
The chief executive officer (president) of the company shall serve from the date of review and approval of the board of directors to the expiration of the ninth board of directors.
-
The latest forecast for 2021: these 10 medicines sell best (list attached)
Time of Update: 2021-03-22
As one of the world's best-selling products, lenalidomide is predicted to have sales of more than 13 billion U.
Data show that the total sales of Ibrutinib in the six years since its listing has reached US$23.
-
Shanxi: Novartis and other three companies adjusted the reference price of online drug purchases
Time of Update: 2021-03-22
On March 10, 2021, the Shanxi Provincial Pharmaceutical Equipment Centralized Bidding Procurement Center issued the "Notice on Adjusting the Reference Price of Online Drug Purchases by Beijing Novartis Pharmaceutical Co.
The purchase reference price of valsartan capsules (trade name: Divin) produced by Beijing Novartis Pharmaceutical Co.
-
Insulin or take the lead in centralized procurement market pattern or face remodeling
Time of Update: 2021-03-22
Some analysts pointed out that with the advancement of centralized insulin procurement, domestic companies are expected to rely on price advantages to realize import substitution, achieve national market access, and gain a larger market share, thereby realizing a reshuffle of the industry's competitive landscape.
-
The state announced a 40% increase in the salary of the health center staff in this place
Time of Update: 2021-03-22
Performance reform of township hospitals, medical staff salaries increased by more than 40% The case shows that Hanyin County has promoted the reform of the salary system, fully implemented the "two permits", and established the township health center's incentive mechanism for the "Public Welfare Type One Guarantee, and Public Welfare Type Two Management".
-
National Medical Insurance Administration, the latest development of medical insurance payment reform
Time of Update: 2021-03-22
As early as May 2019, the National Medical Insurance Administration announced a list of 30 DRG-paying national pilot cities, and then released 376 ADRG groups and 618 DRG sub-groups in October 2019 and June 2020, respectively, to further promote DRG Payment reform.
-
The story of Coley's Toxins
Time of Update: 2021-03-22
Unfortunately, this therapy failed to pass GMP production standards and modern clinical trials in time and was listed as an unproven therapy by the FDA in 1963.
Later, chemotherapy and radiotherapy with clearer mechanisms and more controllable production entered tumor treatment successively, and this toxin therapy began to be squeezed out.
